| | Disease duration, years | 12.70 (SD 9.52), min–max (1–40) | | Rodnan skin thickness score | 13.30 (SD 7.21), min–max (2–30) | | Subtype of systemic sclerosis | | | Limited nr, % | 35, 74.5% | | Diffuse nr, % | 12, 25.5% | | Capillaroscopy evaluation | | | Active nr, % | 17, 36.2% | | Late nr, % | 20, 42.6% | | Early nr, % | 10, 21.3% | | Treatment during the last half a year | | | ACE inhibitors nr, % | 8, 17.0% | | Calcium channels blockers nr, % | 37, 78.7% | | Methotrexate nr, % | 8, 17.0% | | Azathioprine nr, % | 8, 17.0% | | Antimalarials nr, % | 5, 10.64% | | Steroids nr, % | 23, 48.94% |
|
|
